300 East 66th StreetFloors 1 - 4New York, NY 10065
Overview of Dr. Iyengar
Dr. Neil Iyengar is a medical oncologist and clinical-translational researcher at Memorial Sloan Kettering Cancer Center (MSKCC) where he specializes in the care of patients with breast cancer. He also holds joint research appointments at the Rockefeller University Center for Clinical and Translational Science and Weill Cornell Medical College (WCMC) in New York. He received his undergraduate and medical degrees from the University of Illinois College of Medicine accelerated program in Chicago. He then went on to complete residency training in Internal Medicine at the University of Chicago followed by fellowship in medical oncology and hematology at MSKCC. Dr. Iyengar studies the role of obesity and inflammation in the development and progression of breast and several other cancers. He is Co-Leader of the MSKCC-WCMC Obesity & Cancer Working Group, a multi-institutional translational research team composed of laboratory scientists and clinicians. This group was the first to report obesity-related inflammation in the breast as a putative mechanism of carcinogenesis. Dr. Iyengar has been recognized for his work by several organizations including the Conquer Cancer Foundation of the American Society of Clinical Oncology, the Breast Cancer Research Foundation, National Comprehensive Cancer Network, the American Association for Cancer Research, and others. He has been invited to present his work at international meetings and he has published several peer reviewed articles. Dr. Iyengar is now expanding his work to develop specific interventions, including diets, exercise programs, and medications, that target adipose tissue inflammation in order to protect patients from its harmful cancer-promoting effects.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
University of ChicagoResidency, Internal Medicine, 2008 - 2011
University of Illinois College of MedicineClass of 2008
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 2011 - 2026
NJ State Medical License 2020 - 2025
IL State Medical License 2008 - 2011
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Body Composition and White Adipose Tissue Inflammation Start of enrollment: 2015 Nov 04
- Exercise Treatment With Standard Therapy for Metastatic Breast Cancer Start of enrollment: 2019 Jun 12
- Researching the Effect of Aerobic Exercise on Cancer Start of enrollment: 2019 Jun 20
- Join now to see all
Publications & Presentations
PubMed
- A Co-Clinical Trial of Exercise Therapy in Breast Cancer Prevention.Lee W Jones, Jessica A Lavery, Brandon L Tsai, Chaya S Moskowitz, Catherine P Lee
Clinical Cancer Research. 2025-04-04 - Cardio-oncology rehabilitation and exercise: evidence, priorities, and research standards from the ICOS-CORE working group.Scott C Adams, Fernando Rivera-Theurel, Jessica M Scott, Michelle B Nadler, Stephen Foulkes
European Heart Journal. 2025-02-28 - Fueling metabolic disruption via FMD to boost chemotherapy in TNBC.Marcus D Goncalves, Neil M Iyengar
Cell Metabolism. 2025-02-04
Press Mentions
What Is Patient Advocacy, the Pivotal Shift in Healthcare Gaining Currency?January 31st, 2025- Considerations on the Use of GLP-1 Drugs in Breast Cancer PatientsJanuary 30th, 2025
- Link, Study SuggestsJanuary 28th, 2025
- Join now to see all
Grant Support
- Breast White Adipose Tissue Inflammation and Breast Cancer OutcomesKAISER FOUNDATION RESEARCH INSTITUTE2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
